briumvi
neuraxpharm pharmaceuticals s.l. - ublituximab - multiple sclerosis, relapsing-remitting; multiple sclerosis - immunszuppresszánsok - briumvi is indicated for the treatment of adult patients with relapsing forms of multiple sclerosis (rms) with active disease defined by clinical or imaging features.
levofloxacin altan 5 mg/ml oldatos infúzió
altan pharma ltd. - levofloxacin -
zoledronsav richter calciplusd oldatos infúzió és filmtabletta
richter gedeon nyrt. - zoledronic acid; cholecalciferol; calcium -
aggrastat 0,05 mg/ml oldatos infúzió
iroko cardio (uk) ltd. - tirofiban -
tresuvi 1 mg/ml oldatos infúzió
amomed pharma gmbh - treprostinil -
tresuvi 2,5 mg/ml oldatos infúzió
amomed pharma gmbh - treprostinil -
tresuvi 5 mg/ml oldatos infúzió
amomed pharma gmbh - treprostinil -
pedmarqsi
fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - minden más terápiás készítmény - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.
miacalcic 50 ne/ml oldatos injekció és infúzió
essential pharma (m) ltd. - calcitonin (lazac) -
glükóz 5% "baxter" infúzió 100 ml
baxter (hungary) kft. - glükóz, vízmentes -